Antibiotice S.A. (BVB: ATB)

Antibiotice Income Statement

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	655.41	614.16	497.5	376.76	346.78	394.37
Other Revenue	2.48	1.12	7.5	2.07	0.45	0.78
Revenue	657.89	615.29	505	378.83	347.22	395.15
Revenue Growth (YoY)	8.76%	21.84%	33.31%	9.10%	-12.13%	7.17%
Cost of Revenue	242.29	230.09	187.45	146.97	109.56	143.06
Gross Profit	415.6	385.19	317.55	231.86	237.66	252.09
Selling, General & Admin	165.96	161.69	130.53	125.92	118.01	108.39
Other Operating Expenses	108.39	98.2	91.94	47.57	60.43	82.55
Operating Expenses	314.75	287.77	244.73	197.61	200.24	212.35
Operating Income	100.85	97.42	72.81	34.25	37.42	39.74
Interest Expense	-4.37	-4.15	-3.59	-3.52	-4.93	-4.69
Interest & Investment Income	0	0	0	0	0	0.01
Currency Exchange Gain (Loss)	-0.73	-0.95	-0.8	-0.22	-3.72	0.11
Other Non Operating Income (Expenses)	0.01	0.08	-0.18	-0.21	-0.44	0.02
EBT Excluding Unusual Items	95.76	92.42	68.25	30.3	28.33	35.18
Gain (Loss) on Sale of Assets	0.16	0	0.1	-	-	-
Asset Writedown	-0.9	-0.9	-3.04	-	-	-
Pretax Income	95.03	91.52	65.31	30.3	28.33	35.18
Income Tax Expense	2.74	10.44	13.84	0.36	1.94	4.36
Net Income	92.29	81.09	51.47	29.94	26.39	30.82
Net Income to Common	92.29	81.09	51.47	29.94	26.39	30.82
Net Income Growth	-6.51%	57.54%	71.92%	13.46%	-14.39%	-10.15%
Shares Outstanding (Basic)	671	671	671	671	671	671
Shares Outstanding (Diluted)	671	671	671	671	671	671
Shares Change (YoY)	0.03%	-	-	-	-	-
EPS (Basic)	0.14	0.12	0.08	0.04	0.04	0.05
EPS (Diluted)	0.14	0.12	0.08	0.04	0.04	0.05
EPS Growth	-6.54%	57.54%	71.92%	13.46%	-14.39%	-10.15%
Free Cash Flow	44.23	39.43	78.09	15.39	46.06	-48.56
Free Cash Flow Per Share	0.07	0.06	0.12	0.02	0.07	-0.07
Dividend Per Share	0.083	0.083	0.008	0.003	0.003	0.030
Dividend Growth	946.74%	946.74%	147.72%	-3.27%	-88.94%	199.04%
Gross Margin	63.17%	62.60%	62.88%	61.20%	68.45%	63.80%
Operating Margin	15.33%	15.83%	14.42%	9.04%	10.78%	10.06%
Profit Margin	14.03%	13.18%	10.19%	7.90%	7.60%	7.80%
Free Cash Flow Margin	6.72%	6.41%	15.46%	4.06%	13.27%	-12.29%
EBITDA	141.29	125.35	95.38	58.68	59.52	61.46
EBITDA Margin	21.48%	20.37%	18.89%	15.49%	17.14%	15.55%
D&A For EBITDA	40.45	27.93	22.57	24.43	22.1	21.72
EBIT	100.85	97.42	72.81	34.25	37.42	39.74
EBIT Margin	15.33%	15.83%	14.42%	9.04%	10.78%	10.06%
Effective Tax Rate	2.88%	11.40%	21.19%	1.20%	6.85%	12.38%
Advertising Expenses	-	-	-	11.01	8.69	7.74

Source: S&P Capital IQ. Standard template. Financial Sources.